SHAREHOLDER ALERT: Law firm Pomerantz is investigating claims on behalf of investors in Bakkt Holdings, Inc.


New York, New York – (Newsfile Corp. – November 28, 2021) – Pomerantz LLP is investigating claims on behalf of investors from Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT). These investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation aims to determine whether Bakkt and any of its officers and / or directors have engaged in securities fraud or other illegal business practices.

[Click here for information about joining the class action]

On November 22, 2021, in a filing with the United States Securities and Exchange Commission, Bakkt disclosed that the management of the Company “reassessed the application of ASC 480-10-S99-3A to the classification accounting for Class A common shares, par value $ 0.0001 (the “Class A Common Shares”) of VPC Acquisition Impact Holdings (“HIV”).. which were issued in connection with the initial public offering. spares HIV (the “IPO”), and identified errors in HIV reporting[…]relating to the misclassification (the “misclassification”) of the Class A common share “and” has determined that it is appropriate to restate certain of the condensed consolidated financial statements of HIV[.]”

Following this news, the Bakkt share price fell $ 2.65 per share, or 13.47%, to close at $ 17.02 per share on November 22, 2021.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris and Tel Aviv, is recognized as one of the leading firms in the areas of corporate, securities and antitrust litigation. Founded by the late Abraham L. Pomerantz, known as the Dean of the Class Actions Bar, Pomerantz was a pioneer in the field of securities class actions. Today, more than 85 years later, Pomerantz continues the tradition he established, fighting for the rights of victims of securities fraud, breach of fiduciary duty and professional misconduct. The firm has recovered numerous multi-million dollar damages on behalf of the members of the group. See

Robert S. Willoughby
Pomerantz srl
[email protected]
888-476-6529 ext 7980

To view the source version of this press release, please visit


About Author

Comments are closed.